MedPath

Skintel Integration Study

Not Applicable
Completed
Conditions
Skin Type From I-VI on Non-hair Bearing Skin
Interventions
Device: Skintel
Registration Number
NCT02130609
Lead Sponsor
Cynosure, Inc.
Brief Summary

The objective of this study is to improve the treatment guidelines for the Elite+ by determining the maximum safe settings for skin and correlate them to measurement of Melanin Index (MI) (MI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • 18 years and older
  • Able to read, understand, and sign the Informed Consent Form
  • Willing and able to comply with all study requirements
Exclusion Criteria
  • Hypersensitivity to light in the near infrared wavelength region
  • Sun-damaged skin (treatment contraindicated with Alex laser only)
  • Unprotected sun exposure (for Alex laser within four weeks of treatment; for
  • Nd:YAG laser within one week of treatment), including the use of tanning beds or
  • tanning products, such as creams, lotions and sprays
  • Take medication which is known to increase sensitivity to sunlight
  • Seizure disorders triggered by light
  • Take anticoagulants
  • Take or have taken oral isotretinoin, such as Accutane®, within the last six months
  • Take medication that alters the wound-healing response
  • History of healing problems or history of keloid formation
  • Active localized or systemic infection, or an open wound in area being treated
  • Significant systemic illness or an illness localized in area being treated
  • History of skin cancer or suspicious lesions
  • Lupus
  • Have received or are receiving or gold therapy
  • Pregnancy, planning on becoming pregnant or have been pregnant recently

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SkintelSkintel-
Primary Outcome Measures
NameTimeMethod
improve the treatment guidelines for the Elite+ by determining the maximum safe settings for skin and correlate them to measurement of Melanin Index9 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath